"Vitamin K" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.
Descriptor ID |
D014812
|
MeSH Number(s) |
D02.455.426.559.847.638.721.374 D02.455.849.291.523.500 D04.615.638.721.374
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vitamin K".
Below are MeSH descriptors whose meaning is more specific than "Vitamin K".
This graph shows the total number of publications written about "Vitamin K" by people in this website by year, and whether "Vitamin K" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitamin K" by people in Profiles.
-
Late-Onset Vitamin K Deficiency Presenting as Scrotal Bruising and Mediastinal Mass. Pediatr Emerg Care. 2019 Oct; 35(10):e192-e193.
-
The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey. Adv Ther. 2017 08; 34(8):2043-2057.
-
Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017 Jul 18; 6(7).
-
Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients. Heart. 2015 Feb; 101(4):264-70.
-
Vitamin K: a structural basis for the design of novel neuroprotective agents? Future Med Chem. 2013 May; 5(8):857-60.
-
Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents. J Med Chem. 2013 Feb 14; 56(3):1007-22.
-
Using median regression to obtain adjusted estimates of central tendency for skewed laboratory and epidemiologic data. Clin Chem. 2009 Jan; 55(1):165-9.
-
Intraoperative recombinant activated factor VII for emergent epidural hematoma evacuation. Anesth Analg. 2004 Aug; 99(2):595-7, table of contents.
-
Antenatal vitamin K therapy of the low-birth-weight infant. Am J Obstet Gynecol. 1994 Jan; 170(1 Pt 1):85-9.
-
Prenatal vitamin K for low birth weight infants. Int J Artif Organs. 1993 Apr; 16(4):175-6.